Philosys Co., Ltd. announced that it expects to receive KRW 4 billion in funding from Dongwha Pharm.Co.,Ltd
April 22, 2018
Share
Philosys Co., Ltd. announced a private placement of 15th series unregistered unguaranteed convertible bonds for gross proceeds of KRW 2,000,000,000 on April 23, 2018. The 15th series bonds transaction will include participation from Dongwha Pharm.Co.,Ltd (KOSE:A000020). The bonds will not carry any coupon rate and yield to maturity of 1%. The bond would mature on April 23, 2023. The bond will be 100% convertible into 666,666 common shares for 2.42% stake of the company at a fixed conversion price of KRW 3,000 per share from October 24, 2018 to April 22, 2018. The transaction is expected to close on April 24, 2018. The transaction has been approved by the board of directors of the company.
On the same date, the company announced another private placement of 16th series unregistered unguaranteed convertible bonds for gross proceeds of KRW 2,000,000,000. The 16th series bonds transaction will include participation from Bokwang Sports-IT Investment Fund 22 and Bokwang Youth Job Creation Investment Fund 23 for KRW 1,000,000,000 each. The bonds will not carry any coupon rate and yield to maturity of 6%. The bond would mature on April 25, 2023. The bond will be 100% convertible into 666,666 common shares for 2.42% stake of the company at a fixed conversion price of KRW 3,000 per share from July 25, 2018 to April 24, 2023. The transaction is expected to close on April 26, 2018. The transaction has been approved by the board of directors of the company.
DONGWHA PHARM.CO., LTD is a Korea-based company engaged in the manufacture of pharmaceuticals. The Companyâs products consist of ethical drugs, including digestive system remedies, antibiotics, cardiovascular and metabolic disease treatments, non steroidal anti-inflammatory drugs, respiratory remedies, muscle relaxants, nervous system remedies, dermatological remedies and urinary system remedies, and over-the-counter (OTC) drugs, including cold remedies, dental remedies, dermatological remedies, hepatic protectors, nutrients, tonics, topical analgesics, anti-smoking agents and others. It also provides medicine raw materials, health food and drinks, as well as cosmetics. The Company distributes its products within domestic market and to overseas markets.